270 related articles for article (PubMed ID: 6134820)
1. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
2. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
3. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
4. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
5. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
[TBL] [Abstract][Full Text] [Related]
6. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
Nishimura T; Kita S; Abiko Y
J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
[TBL] [Abstract][Full Text] [Related]
8. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits.
Reverte M; Rivas-CabaƱero L
Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403
[TBL] [Abstract][Full Text] [Related]
9. Differential role of adrenoceptors in control of plasma glucose and fatty acids in carp, Cyprinus carpio (L.).
van den Thillart G; Vianen G; Ponce MC; Lelieveld H; Nieveen M; Van Raaij M; Steffens A; Zaagsma J
Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R615-24. PubMed ID: 11448867
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).
Bilski AJ; Halliday SE; Fitzgerald JD; Wale JL
J Cardiovasc Pharmacol; 1983; 5(3):430-7. PubMed ID: 6191142
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
Maruyama Y; Awaji T; Inoue M; Takeo S
Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
[TBL] [Abstract][Full Text] [Related]
12. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic control of plasma glucose and free fatty acid levels in the air-breathing African catfish Clarias gariepinus Burchell 1822.
van Heeswijk JC; Vianen GJ; van den Thillart GE; Zaagsma J
J Exp Biol; 2005 Jun; 208(Pt 12):2217-25. PubMed ID: 15939765
[TBL] [Abstract][Full Text] [Related]
14. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of exercise-induced metabolic responses during selective beta 1- and beta 2-antagonism.
Hespel P; Lijnen P; Vanhees L; Fagard R; Fiocchi R; Moerman E; Amery A
Med Sci Sports Exerc; 1986 Apr; 18(2):186-91. PubMed ID: 3010028
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of metabolic adrenoceptors.
Loakpradit T; Lockwood R
Br J Pharmacol; 1977 Jan; 59(1):135-40. PubMed ID: 13899
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
Pringle TH; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
[TBL] [Abstract][Full Text] [Related]
19. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
Schliep HJ; Harting J
J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]